{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:44:02Z","timestamp":1793047442107,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:sec id=\"ab-noi230021-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Although it has been postulated that chronic inflammation caused by rheumatoid arthritis (RA) contributes to the development of Parkinson disease (PD), the association between these 2 conditions has yet to be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi230021-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the association between RA and subsequent PD risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi230021-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study used the Korean National Health Insurance Service database to collect population-based, nationally representative data on patients with RA enrolled from 2010 to 2017 and followed up until 2019 (median follow-up, 4.3 [IQR, 2.6-6.4] years after a 1-year lag). A total of 119\u202f788 patients who were first diagnosed with RA (83\u202f064 with seropositive RA [SPRA], 36\u202f724 with seronegative RA [SNRA]) were identified during the study period and included those who underwent a national health checkup within 2 years before the RA diagnosis date (64\u202f457 patients). After applying exclusion criteria (eg, age &amp;amp;lt;40 years, other rheumatic diseases, previous PD), 54\u202f680 patients (39\u202f010 with SPRA, 15\u202f670 with SNRA) were included. A 1:5 age- and sex-matched control group of patients without RA was also included for a total control population of 273\u202f400.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi230021-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>\n                      Rheumatoid arthritis as defined using\n                      <jats:italic>International Classification of Diseases, Tenth Revision<\/jats:italic>\n                      codes M05 for SPRA and M06 (except M06.1 and M06.4) for SNRA; prescription of any disease-modifying antirheumatic drug; and enrollment in the Korean Rare and Intractable Diseases program.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi230021-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The main outcome was newly diagnosed PD. Data were analyzed from May 10 through August 1, 2022, using Cox proportional hazards regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi230021-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From the 328\u202f080 individuals analyzed (mean [SD] age, 58.6 [10.1] years; 74.9% female and 25.1% male), 1093 developed PD (803 controls and 290 with RA). Participants with RA had a 1.74-fold higher risk of PD vs controls (95% CI, 1.52-1.99). An increased risk of PD was found in patients with SPRA (adjusted hazard ratio [aHR], 1.95; 95% CI, 1.68-2.26) but not in patients with SNRA (aHR, 1.20; 95% CI, 0.91-1.57). Compared with the SNRA group, those with SPRA had a higher risk of PD (aHR, 1.61; 95% CI, 1.20-2.16). There was no significant interaction between covariates on risk of PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi230021-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, RA was associated with an increased risk of PD, and seropositivity of RA conferred an augmented risk of PD. The findings suggest that physicians should be aware of the elevated risk of PD in patients with RA and promptly refer patients to a neurologist at onset of early motor symptoms of PD without synovitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2023.0932","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T11:00:52Z","timestamp":1682938852000},"page":"634","source":"Crossref","is-referenced-by-count":37,"title":["Rheumatoid Arthritis and Risk of Parkinson Disease in Korea"],"prefix":"10.1001","volume":"80","author":[{"given":"Jihun","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonghee","family":"Eun","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooyoung","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gangneung Asan Hospital, University of Ulsan College, Ulsan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Hee","family":"Cho","sequence":"additional","affiliation":[{"name":"Samsung C&T Medical Clinic, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyoung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun-tae","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"},{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungjin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"},{"name":"Department of Medical Humanities, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"noi230021r1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/archneurol.2010.79","article-title":"LRRK2 and Parkinson disease.","volume":"67","author":"D\u00e4chsel","year":"2010","journal-title":"Arch Neurol"},{"issue":"6","key":"noi230021r2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics.","volume":"16","author":"Tan","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"noi230021r3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases.","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol"},{"issue":"23","key":"noi230021r4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis.","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"noi230021r5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/immunol.1996.14.issue-1","article-title":"Role of cytokines in rheumatoid arthritis.","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"noi230021r6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.1999.100.issue-1","article-title":"Association of circulating TNF-a and IL-6 with ageing and parkinsonism.","volume":"100","author":"Dobbs","year":"1999","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"noi230021r7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","article-title":"Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan.","volume":"50","author":"Chang","year":"2018","journal-title":"Ann Med"},{"issue":"1-4","key":"noi230021r8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden.","volume":"10","author":"Li","year":"2012","journal-title":"Neurodegener Dis"},{"issue":"2","key":"noi230021r9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3233\/JPD-202418","article-title":"Decreased risk of Parkinson\u2019s disease after rheumatoid arthritis diagnosis: a nested case-control study with matched cases and controls.","volume":"11","author":"Bacelis","year":"2021","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"noi230021r10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.mayocp.2016.06.023","article-title":"Reduced risk of Parkinson disease in patients with rheumatoid arthritis: a nationwide population-based study.","volume":"91","author":"Sung","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"18","key":"noi230021r11","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease: a population-based case-control study.","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"noi230021r12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/mds.v35.2","article-title":"Body mass index, diabetes, and the risk of Parkinson\u2019s disease.","volume":"35","author":"Jeong","year":"2020","journal-title":"Mov Disord"},{"issue":"9","key":"noi230021r13","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2337\/dc19-0760","article-title":"Association between glycemic status and the risk of Parkinson disease: a nationwide population-based study.","volume":"43","author":"Rhee","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"noi230021r14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mds.v34.7","article-title":"Association of statin use with Parkinson\u2019s disease: dose-response relationship.","volume":"34","author":"Jeong","year":"2019","journal-title":"Mov Disord"},{"issue":"12","key":"noi230021r15","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s00296-013-2833-x","article-title":"Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database.","volume":"33","author":"Cho","year":"2013","journal-title":"Rheumatol Int"},{"issue":"3","key":"noi230021r16","first-page":"799","article-title":"Data resource profile: the national health information database of the National Health Insurance Service in South Korea.","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"8","key":"noi230021r17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/mds.v34.8","article-title":"Chronic renal dysfunction, proteinuria, and risk of Parkinson\u2019s disease in the elderly.","volume":"34","author":"Nam","year":"2019","journal-title":"Mov Disord"},{"issue":"1","key":"noi230021r18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.23838\/pfm.2021.00135","article-title":"National General Health Screening Program in Korea: history, current status, and future direction.","volume":"6","author":"Shin","year":"2022","journal-title":"Precision and Future Medicine"},{"issue":"10","key":"noi230021r19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.v33.10","article-title":"Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"33","author":"Postuma","year":"2018","journal-title":"Mov Disord"},{"issue":"3","key":"noi230021r20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"noi230021r21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12877-019-1332-7","article-title":"Trends in the incidence and prevalence of Parkinson\u2019s disease in Korea: a nationwide, population-based study.","volume":"19","author":"Park","year":"2019","journal-title":"BMC Geriatr"},{"issue":"3","key":"noi230021r22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease.","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Ann Neurol"},{"issue":"1","key":"noi230021r23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"noi230021r24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamacardio.2016.1326","article-title":"Recent trends in cardiovascular mortality in the United States and public health goals.","volume":"1","author":"Sidney","year":"2016","journal-title":"JAMA Cardiol"},{"key":"noi230021r25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fncel.2013.00053","article-title":"Interleukin-1\u00df and tumor necrosis factor-a: reliable targets for protective therapies in Parkinson\u2019s disease?","volume":"7","author":"Leal","year":"2013","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"noi230021r26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp Neurol"},{"issue":"1","key":"noi230021r27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1\u00df in the substantia nigra.","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"37","key":"noi230021r28","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease.","volume":"26","author":"McCoy","year":"2006","journal-title":"J Neurosci"},{"issue":"1","key":"noi230021r29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death.","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"noi230021r30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","article-title":"Pathological a-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation.","volume":"265","author":"Zhang","year":"2017","journal-title":"Toxicol Lett"},{"issue":"1","key":"noi230021r31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease.","volume":"167","author":"Chen","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"12","key":"noi230021r32","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3899\/jrheum.140082","article-title":"Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis.","volume":"41","author":"Barra","year":"2014","journal-title":"J Rheumatol"},{"issue":"5","key":"noi230021r33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/acr.20207","article-title":"Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.","volume":"62","author":"Farragher","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"noi230021r34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.17305\/bjbms.2010.2729","article-title":"Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis.","volume":"10","author":"Sahat\u00e7iu-Meka","year":"2010","journal-title":"Bosn J Basic Med Sci"},{"issue":"13","key":"noi230021r36","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1084\/jem.20110640","article-title":"Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells.","volume":"208","author":"Ireland","year":"2011","journal-title":"J Exp Med"},{"issue":"8","key":"noi230021r37","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/rheumatology\/kew178","article-title":"Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies.","volume":"55","author":"Sorice","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"noi230021r38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease.","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat Med"},{"issue":"37","key":"noi230021r39","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease.","volume":"30","author":"Dehay","year":"2010","journal-title":"J Neurosci"},{"issue":"12","key":"noi230021r40","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains.","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch Neurol"},{"issue":"9","key":"noi230021r41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10654-020-00672-x","article-title":"Female reproductive factors and the risk of Parkinson\u2019s disease: a nationwide cohort study.","volume":"35","author":"Yoo","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"noi230021r42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.parkreldis.2021.10.030","article-title":"Sex differences in the association between nonalcoholic fatty liver disease and Parkinson\u2019s disease.","volume":"93","author":"Jeong","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"noi230021r43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease.","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol"},{"issue":"16","key":"noi230021r44","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1212\/WNL.0b013e3181bd13a1","article-title":"Family history of melanoma and Parkinson disease risk.","volume":"73","author":"Gao","year":"2009","journal-title":"Neurology"},{"key":"noi230021r45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/pharmtox.2014.54.issue-1","article-title":"Environmental toxins and Parkinson\u2019s disease.","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"noi230021r46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ypmed.2014.11.007","article-title":"Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: a nationwide cohort study.","volume":"70","author":"Lee","year":"2015","journal-title":"Prev Med"},{"key":"noi230021r35","first-page":"380","article-title":"POS0309 seropositivity increases risk of incident dementia in individuals with rheumatoid arthritis: a population-based cohort study.","volume-title":"Ann Rheum Dis","author":"Kronzer","year":"2021"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2804530\/jamaneurology_kang_2023_oi_230021_1686342386.85697.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:05:12Z","timestamp":1686567912000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2804530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.0932","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}